Clinical Trial Update: Adalat XL vs Diltiazem on Proteinuria and Blood Pressure in Hypertensive Diabetic Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Adalat XL to Diltiazem in hypertensive patients with diabetic nephropathy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Hypertension

Drugs mentioned

• Adalat XL (nifedipine)
• Diltiazem (diltiazem)

Snippet

Sponsor: Bayer | Conditions: Diabetic Nephropathies, Hypertension | Phase 3 | Status: WITHDRAWN